~~<i id='EEBB831ACB'><strike id='EEBB831ACB'><tt id='EEBB831ACB'><pre id='EEBB831ACB'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

leisure time

author：hotspot 2025-09-29 21:02:26 - browse：74487

A green number 3 with an eye is surrounded by smaller, black number 3s on a purple background — 3 to watch coverage from STAT — Christine Kao/STAT

Life in the CRISPR lane tends to move at lightning speed. This year saw the first-ever approval of a medicine based on the gene editing technology, barely more than a decade after publication of its first demonstration by Nobel laureates Jennifer Doudna and Emmanuelle Charpentier.

The landmark decision paves the way for in vivo therapies, which edit cells inside the body, to reach patients, as well as treatments based on more efficient genome editors with fancier DNA-altering tricks up their sleeves.

Here are three CRISPR developments we’re watching in 2024:

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： Grail faces three suits alleging harassment, retaliation

hotspot

entertainment

focus

knowledge

focus

MinkslookoutfromacageatafurfarminBelarus.SergeiGrits/APHELSINKI—ItwasthequietthatstoodouttoTarjaSiro

WSS

Illinois Supreme Court finds assault weapons ban constitutional

Blood tests recalled over risk of missed heart attack diagnosis

Elon Musk says Twitter has 'negative cash flow' and 'heavy debt'

Global childhood vaccinations edge closer to pre

Grail faces three suits alleging harassment, retaliation

Judge sides with young activists in first

knowledge

leisure time

hotspot

In age of alternative facts, a scholarly course on calling out crap

Georgia court denies Trump's request to quash DA's 2020 election probe

ChatGPT in medicine: STAT answers readers' burning questions

Treatments for cramps don't cut it. Why aren't there better options?

Peter Hotez and the public health issue of online harassment

Congress: Eradicate hepatitis C and reduce the deficit

Alkermes shareholders re

Treatments for cramps don't cut it. Why aren't there better options?

What does generative AI mean for health care? We asked experts

Montana youths win climate lawsuit against state for promoting fossil fuels

entertainment

Dozens dead from Maui wildfires: What we know about the victims

BMS, looking to build heart drug business, turns to AI for diagnosis

Bird flu researchers hone in on Finland’s mink farms

Special counsel informs Trump he is target in probe of efforts to overturn 2020 election

After Optum profits sink, UnitedHealth makes changes

Woman gored by Bison at Yellowstone

focus

knowledge

focus

focus